Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Frontiers in Toxicology
ISSN 2673-3080 · Frontiers Media S.A. · Switzerland
Frontiers in Toxicology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 5.1 (journal website); fully open access; APC charged, amount not published; median 68 days to acceptance (108 articles, last 24 months); 158 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Toxicology is published by Frontiers Media S.A. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Effects and risks of endocrine disrupting chemicals, Animal testing and alternatives and Carcinogens and Genotoxicity Assessment, together about 31% of its articles. Its main subfields are Health, Toxicology and Mutagenesis. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Toxicology is a multidisciplinary journal presenting the latest research on the adverse effects of substances, particles, and mixtures on living organisms and ecosystems, from molecular mechanisms to population level effects. Led by Prof. Bengt Fadeel (Karolinska Institutet, Stockholm, Sweden), Frontiers in Toxicology welcomes research contributions in the various domains of toxicology, bridging the gap between scientific discoveries and their practical applications. Topics include, but are not limited to: adverse effects of exposure to drugs, pharmaceuticals, chemicals, and toxins development and implementation of new approach methodologies (NAMs) development and implementation of regulatory guidelines and policies exposure assessment and interventions to promote safer working environments human health and environmental concerns associated with nanomaterials impact of pollutants, contaminants, and chemicals on ecosystems and wildlife risk assessment of chemicals, drugs, and other substances use of computer models and in silico approaches to predict toxicity. In particular, the journal welcomes submissions which support and advance the UN’s Sustainable Development Goal (SDG), notably #3: Good health and well-being. Manuscripts focusing on clinical or medical studies without a connection to Toxicology, including patient analysis, acute disease treatment, and cellular research in a medical context, are not suitable for this journal. Similarly, purely theoretical or analytical research without a foundation in toxicology is not appropriate for this journal. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Toxicology is committed to advancing developments in the field of toxicology by providing unrestricted access to articles and communicating scientific knowledge to researchers, clinicians, regulatory authorities, and industry professionals. It aims to foster a global toxicological research community and facilitate interdisciplinary collaboration. Ethics Statement for the Tobacco Industry In accordance with Frontiers’ Conflict of Interest (COI) policy, for any manuscript that is sponsored through commercial funding, the role of the funder must be declared to Frontiers in Toxicology in
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Editorial board by country: none in mainland China; most named Denmark 3, United States 2, Italy 2, Sweden 2, Norway 2 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Effects and risks of endocrine disrupting chemicalsEnvironmental Science15.1%
- Animal testing and alternativesVeterinary9.5%
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology6.3%
- Nanoparticles: synthesis and applicationsMaterials Science6.1%
- Microplastics and Plastic PollutionEnvironmental Science6%
- Toxic Organic Pollutants ImpactEnvironmental Science5.8%
- Computational Drug Discovery MethodsComputer Science5.2%
- Air Quality and Health ImpactsEnvironmental Science4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Toxicology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 5.1Publisher website ·
- CiteScore 2026-06
- 7.5LetPub ·
- CiteScore (publisher)
- 7.5Publisher website ·
- SJR 2026-06
- 1.33LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 244OpenAlex ·
- 2-year mean citedness
- 4.64OpenAlex ·
- Self-citation rate
- 3.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 141LetPub ·
Articles by year OpenAlex count · 808 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 205 | 205 | 148 |
| 2025 | 158 | 158 | 710 |
| 2024 | 129 | 129 | 1,427 |
| 2023 | 103 | 103 | 1,587 |
| 2022 | 146 | 146 | 3,556 |
| 2021 | 59 | 59 | 1,841 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
68 daysMedian, submission to acceptance · P25–P75 43 days – 101 days
- Acceptance to online
- median 25 days (108 articles)
- Submission to online
- median 94 days
- Sample
- 108 articles with submission and acceptance dates (383 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 2,550 | Yes | CC BY | |
| OpenAlex | CHF 2,550 | — | — | |
| LetPub | USD 2,125 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Keywords
- 5–8
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures, tables, and images published under CC-BY; permission required for copyrighted third-party material. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Open access under CC-BY license (version 4.0) for all articles from July 2012 onwards; authors retain copyright. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Manuscripts must meet international English language standards. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-3080
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Toxicology
What CAS zone is Frontiers in Toxicology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Toxicology is in Zone 4 of Medicine, and in Zone 4 of the minor category Toxicology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Toxicology?
The journal's website gives an impact factor of 5.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 7.5, h-index 40.
How long does peer review take at Frontiers in Toxicology?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 43–101 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Frontiers in Toxicology based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Denmark (3), United States (2) and Italy (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Toxicology?
According to LetPub and DOAJ records, Frontiers in Toxicology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Toxicology open access, and what is the APC?
Frontiers in Toxicology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .